BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

4847

543308

KIMS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

KRISHNA INST OF MED SCI L performance

Today’s low

Today’s high

₹ 653.00 ₹ 676.95
₹ 656.85

52 week low

52 week high

₹ 350.00 ₹ 708.00
₹ 656.85

Open Price

₹ 673.00

Prev. Close

₹ 676.30

Volume (Shares)

574185.00

Total traded value

₹ 3771.53

Upper Circuit

₹ 811.55

Lower Circuit

₹ 541.05

info

KRISHNA INST OF MED SCI L Share Price Update

As of the latest trading session, KRISHNA INST OF MED SCI L share price is currently at ₹ 656.85, which is down by ₹ -19.45 from its previous closing. Today, the stock has fluctuated between ₹ 653.00 and ₹ 676.95. Over the past year, KRISHNA INST OF MED SCI L has achieved a return of 66.76 %. In the last month alone, the return has been 9.39 %. Read More...

KRISHNA INST OF MED SCI L fundamentals


  • Market cap (Cr)

    5,256.62

  • P/E Ratio (TTM)

    102.07

  • Beta

    0.59

  • Book Value / share

    49.93

  • Return on equity

    13.46%

  • EPS (TTM)

    6.44

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    76.50

info icon alternate text
  • Market cap (Cr)

    5,266.22

  • P/E Ratio (TTM)

    102.07

  • Beta

    0.61

  • Book Value / share

    49.93

  • Return on equity

    13.46%

  • EPS (TTM)

    6.44

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    76.50

info icon alternate text

KRISHNA INST OF MED SCI L Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 347.50
Operating Expense 266.20
Net Profit 76.50
Net Profit Margin (%) 22.01
Earnings Per Share (EPS) 1.91
EBITDA 123.50
Effective Tax Rate (%) 24.92
Particulars SEP 2024 (Values in Cr)
Revenue 363.30
Operating Expense 270.80
Net Profit 72.20
Net Profit Margin (%) 19.87
Earnings Per Share (EPS) 1.80
EBITDA 117.69
Effective Tax Rate (%) 27.14
Particulars JUN 2024 (Values in Cr)
Revenue 327.40
Operating Expense 251.10
Net Profit 60.70
Net Profit Margin (%) 18.54
Earnings Per Share (EPS) 7.58
EBITDA 99.10
Effective Tax Rate (%) 25.61
Particulars MAR 2024 (Values in Cr)
Revenue 304.80
Operating Expense 241.20
Net Profit 48.20
Net Profit Margin (%) 15.81
Earnings Per Share (EPS) 6.02
EBITDA 90.19
Effective Tax Rate (%) 28.59
Particulars DEC 2023 (Values in Cr)
Revenue 302.06
Operating Expense 228.59
Net Profit 58.36
Net Profit Margin (%) 19.32
Earnings Per Share (EPS) 7.29
EBITDA 91.71
Effective Tax Rate (%) 24.90
Particulars MAR 2024 (Values in Cr)
Revenue 1222.10
Operating Expense 919.40
Net Profit 235.30
Net Profit Margin (%) 19.25
Earnings Per Share (EPS) 29.41
EBITDA 379.90
Effective Tax Rate (%) 26.05
Particulars MAR 2023 (Values in Cr)
Revenue 1132.02
Operating Expense 818.18
Net Profit 252.49
Net Profit Margin (%) 22.30
Earnings Per Share (EPS) 31.55
EBITDA 383.78
Effective Tax Rate (%) 25.15
Particulars MAR 2022 (Values in Cr)
Revenue 1143.38
Operating Expense 796.55
Net Profit 278.37
Net Profit Margin (%) 24.34
Earnings Per Share (EPS) 35.04
EBITDA 420.39
Effective Tax Rate (%) 24.97
Particulars MAR 2021 (Values in Cr)
Revenue 932.69
Operating Expense 688.04
Net Profit 188.65
Net Profit Margin (%) 20.22
Earnings Per Share (EPS) 25.20
EBITDA 313.64
Effective Tax Rate (%) 25.80
Particulars MAR 2020 (Values in Cr)
Revenue 789.97
Operating Expense 650.56
Net Profit 121.11
Net Profit Margin (%) 15.33
Earnings Per Share (EPS) 16.26
EBITDA 209.73
Effective Tax Rate (%) 17.33
Particulars MAR 2024 (Values in Cr)
Book Value / Share 228.46
ROE % 19.21
ROCE % 18.40
Total Debt to Total Equity 0.58
EBITDA Margin 26.45
Particulars MAR 2023 (Values in Cr)
Book Value / Share 208.62
ROE % 23.93
ROCE % 25.90
Total Debt to Total Equity 0.31
EBITDA Margin 29.64
Particulars MAR 2022 (Values in Cr)
Book Value / Share 173.35
ROE % 29.70
ROCE % 32.75
Total Debt to Total Equity 0.25
EBITDA Margin 33.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 111.32
ROE % 23.33
ROCE % 25.51
Total Debt to Total Equity 0.47
EBITDA Margin 29.01
Particulars MAR 2020 (Values in Cr)
Book Value / Share 80.25
ROE % 16.75
ROCE % 17.56
Total Debt to Total Equity 0.62
EBITDA Margin 22.76
Particulars MAR 2024 (Values in Cr)
Book Value / Share 233.22
ROE % 13.46
ROCE % 16.77
Total Debt to Total Equity 0.09
EBITDA Margin 31.40
Particulars MAR 2023 (Values in Cr)
Book Value / Share 203.79
ROE % 16.79
ROCE % 22.23
Total Debt to Total Equity 0.01
EBITDA Margin 34.22
Particulars MAR 2022 (Values in Cr)
Book Value / Share 172.13
ROE % 24.15
ROCE % 30.50
Total Debt to Total Equity 0.07
EBITDA Margin 37.16
Particulars MAR 2021 (Values in Cr)
Book Value / Share 116.93
ROE % 21.42
ROCE % 25.83
Total Debt to Total Equity 0.21
EBITDA Margin 34.01
Particulars MAR 2020 (Values in Cr)
Book Value / Share 83.75
ROE % 18.12
ROCE % 19.60
Total Debt to Total Equity 0.33
EBITDA Margin 26.95
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 49.00
Total Assets 3852.01
Total Liabilities 3852.01
Total Equity 2093.23
Share Outstanding 80027787
Price to Book Ratio 8.82
Return on Assets (%) 8.05
Return on Capital (%) 9.88
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 66.37
Total Assets 2941.30
Total Liabilities 2941.30
Total Equity 1937.96
Share Outstanding 80027787
Price to Book Ratio 6.90
Return on Assets (%) 11.43
Return on Capital (%) 13.61
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 190.06
Total Assets 1907.34
Total Liabilities 1907.34
Total Equity 1410.64
Share Outstanding 80027787
Price to Book Ratio 8.02
Return on Assets (%) 17.44
Return on Capital (%) 21.17
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 284.44
Total Assets 1436.15
Total Liabilities 1436.15
Total Equity 876.19
Share Outstanding 77593283
Price to Book Ratio 0.00
Return on Assets (%) 14.01
Return on Capital (%) 17.55
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 45.72
Total Assets 1195.89
Total Liabilities 1195.89
Total Equity 611.43
Share Outstanding 74489552
Price to Book Ratio 0.00
Return on Assets (%) 9.96
Return on Capital (%) 13.39
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 20.48
Total Assets 2396.50
Total Liabilities 2396.50
Total Equity 1866.45
Share Outstanding 80027787
Price to Book Ratio 8.82
Return on Assets (%) 9.82
Return on Capital (%) 10.73
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 40.10
Total Assets 1812.06
Total Liabilities 1812.06
Total Equity 1630.85
Share Outstanding 80027787
Price to Book Ratio 6.90
Return on Assets (%) 13.93
Return on Capital (%) 15.44
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 179.76
Total Assets 1568.78
Total Liabilities 1568.78
Total Equity 1377.54
Share Outstanding 80027787
Price to Book Ratio 8.02
Return on Assets (%) 17.74
Return on Capital (%) 19.94
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 250.01
Total Assets 1213.72
Total Liabilities 1213.72
Total Equity 907.32
Share Outstanding 77593283
Price to Book Ratio 0.00
Return on Assets (%) 15.54
Return on Capital (%) 18.21
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 39.48
Total Assets 957.44
Total Liabilities 957.44
Total Equity 624.13
Share Outstanding 74489552
Price to Book Ratio 0.00
Return on Assets (%) 12.64
Return on Capital (%) 15.66
Particulars MAR 2024 (Values in Cr)
Net Income 459.63
Cash from Operations 661.23
Cash from Investing -752.56
Cash from Financing 216.75
Net change in Cash -14.72
Free Cash Flow 1308.57
Particulars MAR 2023 (Values in Cr)
Net Income 484.90
Cash from Operations 529.32
Cash from Investing -546.89
Cash from Financing 19.64
Net change in Cash -95.16
Free Cash Flow 1103.84
Particulars MAR 2022 (Values in Cr)
Net Income 456.85
Cash from Operations 450.92
Cash from Investing -411.51
Cash from Financing 60.99
Net change in Cash -26.49
Free Cash Flow 621.24
Particulars MAR 2021 (Values in Cr)
Net Income 279.01
Cash from Operations 393.71
Cash from Investing -354.17
Cash from Financing 9.81
Net change in Cash 11.61
Free Cash Flow 488.14
Particulars MAR 2020 (Values in Cr)
Net Income 140.52
Cash from Operations 255.17
Cash from Investing -124.71
Cash from Financing -44.33
Net change in Cash 32.45
Free Cash Flow 307.15
Particulars MAR 2024 (Values in Cr)
Net Income 318.17
Cash from Operations 347.70
Cash from Investing -568.64
Cash from Financing 288.64
Net change in Cash -17.61
Free Cash Flow 668.66
Particulars MAR 2023 (Values in Cr)
Net Income 337.33
Cash from Operations 345.56
Cash from Investing -237.66
Cash from Financing -15.13
Net change in Cash 18.24
Free Cash Flow 466.55
Particulars MAR 2022 (Values in Cr)
Net Income 371.00
Cash from Operations 380.65
Cash from Investing -375.08
Cash from Financing 75.98
Net change in Cash -14.72
Free Cash Flow 450.12
Particulars MAR 2021 (Values in Cr)
Net Income 254.26
Cash from Operations 334.06
Cash from Investing -316.60
Cash from Financing 25.37
Net change in Cash 0.11
Free Cash Flow 406.73
Particulars MAR 2020 (Values in Cr)
Net Income 146.50
Cash from Operations 207.59
Cash from Investing -108.03
Cash from Financing -24.35
Net change in Cash 28.20
Free Cash Flow 228.80
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 76.74 13.41 100542.86 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 78.74 192.05 4.94 147.57 51.01 / 98.70
SHREE PACETRONIX LTD. 71.00 14.79 1.90 25.56 61.11 / 268.50
TRANSGENE BIOTEK LTD. 3.75 0.00 2.62 28.41 3.22 / 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 83.66 12.27 100542.86 5690.80 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 31.25 0.00 -16.74 23.34 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5584.95 29.60 6.27 6109.94 3750.00 / 6400.00

KRISHNA INST OF MED SCI L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
656.85 -2.87 redarrow
red-green-graph indicator
5 Bearish
11 Bullish
  • 5 Days 667.20
  • 26 Days 634.50
  • 10 Days 660.70
  • 50 Days 615.30
  • 12 Days 657.10
  • 100 Days 595.70
  • 20 Days 642.90
  • 200 Days 557.90
674.17 PIVOT

First Support

665.63

First Resistance

684.83

Second Support

654.97

Second Resistance

693.37

Third Support

646.43

Third Resistance

704.03

RSI

63.73

ADX

23.73

MACD

24.37

Williams % R

-17.62

Commodity Channel Index (CCI)

85.69

Date

2025-04-29

Week

589825.00

Same Day

287073.00

Month

389663.00

1 Year

0.59

3 Year

0.50

Over 1 Month

9.39%

down

Over 1 Year

66.76%

down

Over 3 Months

11.20%

down

Over 3 Years

36.14%

down

Over 6 Months

28.35%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

KRISHNA INST OF MED SCI L shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
13.77%
Promoter Holdings
38.81%
FII
15.44%
DII
31.95%
Promoter Shares(Pledge Percentage)
12.03%
Name Shares Category
Bhaskara Rao Bollineni 1.05099645E8 (26.27%) Shareholding of Promoter and Promoter Group
Sbi Small Cap Fund 2.5264693E7 (6.31%) Public Shareholding
Bluebridge Capital Private Limited 2.420331E7 (6.05%) Shareholding of Promoter and Promoter Group
Axis Mutual Fund Trustee Limited A/c Axis Mutual Fund A/c Axis Small Cap Fund 2.0707158E7 (5.17%) Public Shareholding
Hdfc Small Cap Fund 1.7969287E7 (4.49%) Public Shareholding
Bollineni Seenaiah Naidu 1.709309E7 (4.27%) Shareholding of Promoter and Promoter Group
Sbi Life Insurance Co. Ltd 1.408771E7 (3.52%) Public Shareholding
Kotak Small Cap Fund 1.2298116E7 (3.07%) Public Shareholding
Lilac Investments Limited 7850000.0 (1.96%) Public Shareholding
Amansa Holdings Private Limited 7704880.0 (1.93%) Public Shareholding
Nomura India Investment Fund Mother Fund 6868720.0 (1.72%) Public Shareholding
Rajyasri Bollineni 6870015.0 (1.72%) Shareholding of Promoter and Promoter Group
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund 6677451.0 (1.67%) Public Shareholding
Tata Aia Life Insurance Co Ltd-whole Life Mid Cap Equity Fund-ulif 009 04/01/07 Wle 110 5596797.0 (1.4%) Public Shareholding
Venkata Krishna Kumar Kodali 5052800.0 (1.26%) Public Shareholding
Hdfc Life Insurance Company Limited 4751048.0 (1.19%) Public Shareholding
B Krishnaiah 869720.0 (0.22%) Shareholding of Promoter and Promoter Group
Bollineni Aishwarya 707450.0 (0.18%) Shareholding of Promoter and Promoter Group
Abhinay Bollineni 236495.0 (0.06%) Shareholding of Promoter and Promoter Group
Sujatha Bollineni 171930.0 (0.04%) Shareholding of Promoter and Promoter Group
Sweata Raavi 39225.0 (0.01%) Shareholding of Promoter and Promoter Group
Adwik Bollineni 40640.0 (0.01%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

KRISHNA INST OF MED SCI L corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

KRISHNA INST OF MED SCI L Share Price

Krishna Institute of Medical Sciences Limited (KIMS) was erstwhile incorporated as Jagjit Singh and Sons Private Limited', a Private Limited Company on July 26, 1973 in Mumbai. Subsequently, the name of the Company changed to Krishna Institute of Medical Sciences Private Limited' on January 2, 2004 and further upon its conversion to a Public Limited Company, the name was changed to Krishna Institute of Medical Sciences Limited' on January 29, 2004.

The Company is one of the largest corporate groups in India, with hospitals in Telangana, Andhra Pradesh & Maharashtra providing multi-disciplinary integrated services with a focus on tertiary and quaternary healthcare at affordable cost. It is engaged in rendering medical and healthcare services. It operate 12 multi-specialty hospitals under the 'KIMS Hospitals' brand, with an aggregate capacity of over 4,000 beds. It offer a comprehensive range of healthcare services in over 40 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother & child care.

Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. In February 2003, acting in pursuance of the Takeover MoU, certain of its Promoters, namely Dr. Bhaskar Rao Bollineni, Krishnaiah Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company.

Led by Dr. Bhaskar Rao Bollineni, Managing Director and CEO of the Company, a renowned cardiothoracic surgeon, it has grown from a single hospital to a chain of multispecialty hospitals, both organically and through strategic acquisitions. The oldest hospital in their network was established in 2000 at Nellore, by its Corporate Promoter, BRMH, with a capacity of approximately 200 beds and, At present, the hospital network has grown to six multispecialty hospitals in six cities, with a total capacity of 4000 beds, including 1,705 operational beds.

The Hospitals are equipped with state-of-the-art medical equipment and employ practices and policies which help to provide quality healthcare services to their patients. It was one of the first hospitals in Hyderabad to install 4-Arm HD da Vinci Robot technology at Secunderabad hospital. The flagship hospitals at Secunderabad and Rajahmundry have been accredited by the National Accreditation Board for Hospitals and Healthcare Providers, India ('NABH'). The Hospital at Secunderabad is accredited with ISO 9001:2008 certification and has also been accredited by the National Accreditation Board for Testing and Calibration Laboratories ('NABL'). The Hospital situated at Secunderabad was awarded the Healthcare Excellence Award', by the Indo Global Healthcare Summit and Expo, in 2015. It has also received awards from the Association of Healthcare Providers (India) ('AHPI') for nursing excellence, in 2015 and for Patient Friendly Hospital', in 2017. In 2017, it was awarded the best hospital of the year in the multispecialty hospital category in Hyderabad by Times Healthcare Achievers Awards and in 2016 received the Pharmacie DeQualite certification from Bureau Veritas. Further, it was the first hospital in Andhra Pradesh and Telangana to have been Green OT certified in 2016. It is also the laureate of the Asia Pacific Society of Infection Control CSSD Center of Excellence Silver Award 2015-2016. Neurology India Journal has ranked the neurology department at its hospital at Secunderabad as the third biggest centre in India on the basis of volume of epilepsy surgeries performed, as on July 31, 2016.

In addition to healthcare services, the company also conduct medical education programmes through its affiliations with state medical boards and universities, for various broad and super specialties at its hospitals in Secunderabad and Rajahmundry, including for DNB, under graduation, post-graduation, PhD and diploma programmes. It is also affiliated with Kaloji Narayana Rao University of Health Sciences and the Andhra Pradesh Para Medical Board.

During 2022, Sunshine Hospitals became subsidiary of the Company effective from April, 2022.

In 2022-23, the Company opened an exclusive Gastroenterology unit at Vizag.

During FY 2022-23, Sarvejana Healthcare Private Limited became a Subsidiary of the Company effective 01st April 2022; SPANV Medisearch Lifesciences Private Limited became the Subsidiary of Company on 01.09.2022. Suryateja Healthcare Private Limited has ceased to be step down subsidiary of the Company w.e.f. December 01, 2022.

The Nagpur Hospital became functional in 2024. The Company acquired a running hospital of 200 beds-QUEENS NRI HOSPITAL in Vizag, Andhra Pradesh in Jul'24.

Parent organization Indian Private
NSE symbol KIMS
Founded 1973
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Krishna Institute of Medical Sciences Ltd?

Answer Field

The share price of Krishna Institute of Medical Sciences Ltd for NSE is ₹ 656.85 and for BSE is ₹ 658.05.

What is the Market Cap of Krishna Institute of Medical Sciences Ltd?

Answer Field

The market cap of Krishna Institute of Medical Sciences Ltd for NSE is ₹ 52,56.62 Cr. and for BSE is ₹ 52,66.22 Cr. as of now.

What is the 52 Week High and Low of Krishna Institute of Medical Sciences Ltd?

Answer Field

The 52 Week High and Low of Krishna Institute of Medical Sciences Ltd for NSE is ₹ 708.00 and ₹ 350.00 and for BSE is ₹ 707.50 and ₹ 350.02.

How to Buy Krishna Institute of Medical Sciences Ltd share?

Answer Field

You can trade in Krishna Institute of Medical Sciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Krishna Institute of Medical Sciences Ltd?

Answer Field

The 1 year returns on the stock has been 66.76%.

What is the Current Share Price of Krishna Institute of Medical Sciences Ltd?

Answer Field

Krishna Institute of Medical Sciences Ltd share price is for NSE ₹ 656.85 & for BSE ₹ 658.05 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Krishna Institute of Medical Sciences Ltd Share?

Answer Field

The market cap of Krishna Institute of Medical Sciences Ltd for NSE ₹ 52,56.62 & for BSE ₹ 52,66.22 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Krishna Institute of Medical Sciences Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Krishna Institute of Medical Sciences Ltd share is 102.07.

What is the PB ratio of Krishna Institute of Medical Sciences Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Krishna Institute of Medical Sciences Ltd share is 49.93.

How to Buy Krishna Institute of Medical Sciences Ltd Share?

Answer Field

You can trade in Krishna Institute of Medical Sciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Krishna Institute of Medical Sciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Krishna Institute of Medical Sciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Krishna Institute of Medical Sciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|